New Delhi, 19th November: The Office of the Principal Scientific Adviser to the Government of India jointly with the Indian Institute of Science, Bangalore, convened one of its kind S&T Policy summit - 'Dialogue 2023: Expanding Science and Techno
IBM-IISc launch research lab to advance hybrid cloud, AI technology adoption origin-businesstoday.intoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from origin-businesstoday.intoday.in Daily Mail and Mail on Sunday newspapers.
DST funded start-up s ELISA test to better estimate COVID 19 antibody concentration ANI | Updated: May 22, 2021 11:00 IST
The ministry in an official statement said that it was a Bangalore-based start-up that developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID 19 in clinical samples. The handheld device provides the results within five minutes. PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a very significant breakthrough to develop the first of its kind, semi-quantitative Electrochemical ELISA test for COVID-19 IgM and IgG antibodies. While Qualitative analysis detects constituent elements in the sample, the semiquantitative analysis gives an approximate estimation of their concentrations. PathShodh has received the license to manufacture for sale from t
Share
New Delhi: A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID 19 in clinical samples.
PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a very significant breakthrough to develop the first of its kind, semi-quantitative Electrochemical ELISA test for COVID-19 IgM and IgG antibodies. While
Qualitative
semiquantitative analysis gives an approximate
estimation of their concentrations. PathShodh has received the license to manufacture for sale from the Central Drugs Standard Control Organisation (CDSCO), after validation at Translational Health Science and Technology Institute (THSTI), Faridabad, as per the requirements of Indian Council of Medical Research (ICMR).
New Delhi [India], May 22 (ANI): A Bangalore-based start-up has developed a novel, point-of-care Electrochemical ELISA test to estimate accurate antibody concentration of COVID-19 in clinical samples, informed the Union Science and Technology Ministry on Saturday.